Ovid Therapeutics Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on August 13, 2026, covering the quarterly period ended June 30, 2026, disclosing the company's financial condition and operations as a non-accelerated, smaller reporting company listed on NASDAQ:OVID.
Candel Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing its financial condition, operational status, and risk factors as of that date.
Fate Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the fiscal quarter ended June 30, 2026, disclosing financial condition, operational risks, and share count data as of August 6, 2026.
Lifeway Foods, Inc. filed its quarterly report on Form 10-Q with the SEC on August 13, 2026, covering the three and six months ended June 30, 2026, disclosing net sales growth alongside a sharp decline in quarterly net income compared to the prior-year period.
Tapestry, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on August 13, 2026, covering the fiscal year ended June 27, 2026.
Lifeway Foods, Inc. filed a current report on August 13, 2026, disclosing that it issued a press release announcing financial results for the fiscal quarter ended June 30, 2026.
Patricia K. Wagner, a director at Primoris Services Corp (NYSE:PRIM), filed a Form 4 on August 12, 2026, disclosing a transfer of 2,241 shares of common stock to the Wagner Family Trust on August 11, 2026, at no consideration.
Dawn M. Brockman, SVP and Controller at Ameriprise Financial Inc, filed a Form 4 on August 12, 2026, disclosing the sale of 472 shares of common stock on August 10, 2026.
Heather J. Melloh, EVP and General Counsel of Ameriprise Financial Inc, filed a Form 4 on August 12, 2026, disclosing transactions in Ameriprise Financial common stock dated August 10, 2026.
Stefan J. Murry, Chief Financial Officer of Applied Optoelectronics, Inc. (NASDAQ:AAOI), filed a Form 4 on August 12, 2026, disclosing the sale of 4,000 shares of common stock on August 10, 2026.